# Filing Detail

Form DRS - Draft Registration Statement:
SEC Accession No. 0000950123-21-004949
Filing Date
2021-04-26
Accepted
2021-04-26 16:45:17
Documents
8

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | filename1.htm | DRS | 2005178
2 | GRAPHIC | g155225g11d11.jpg | GRAPHIC | 132129
3 | GRAPHIC | g155225g13a00.jpg | GRAPHIC | 120926
4 | GRAPHIC | g155225g22z92.jpg | GRAPHIC | 112079
5 | GRAPHIC | g155225g36n42.jpg | GRAPHIC | 316344
6 | GRAPHIC | g155225g80r72.jpg | GRAPHIC | 178075
7 | GRAPHIC | g155225g92x08.jpg | GRAPHIC | 44812
8 | GRAPHIC | g155225g93a99.jpg | GRAPHIC | 106545
| Complete submission text file | 0000950123-21-004949.txt |  | 3391561

Mailing Address 43 THORNDIKE STREET CAMBRIDGE MA 02141
Business Address 43 THORNDIKE STREET CAMBRIDGE MA 02141 617-683-0917
Amylyx Pharmaceuticals, Inc. (Filer) CIK: 0001658551 (see all company filings)

EIN.: 464600503 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-04729 | Film No.: 21854475
SIC: 2834 Pharmaceutical Preparations